| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| T1015 |
Clinic visit/encounter, all-inclusive |
84,550 |
51,269 |
$8.42M |
| H2020 |
Therapeutic behavioral services, per diem |
739 |
371 |
$85K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
50,201 |
31,888 |
$7K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
19,170 |
12,994 |
$1K |
| 99050 |
|
49 |
22 |
$214.80 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,526 |
1,193 |
$184.06 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,558 |
936 |
$169.72 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
8,791 |
6,558 |
$130.46 |
| 96127 |
|
9,870 |
6,921 |
$118.22 |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
476 |
358 |
$77.25 |
| 3044F |
|
849 |
625 |
$60.00 |
| 90756 |
|
274 |
160 |
$45.58 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
10,410 |
6,694 |
$35.51 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,696 |
1,108 |
$34.13 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
2,233 |
1,464 |
$25.30 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
187 |
116 |
$14.70 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
2,422 |
1,714 |
$10.00 |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
442 |
319 |
$8.26 |
| 3077F |
|
251 |
171 |
$5.00 |
| 99408 |
|
3,460 |
2,784 |
$3.75 |
| 81003 |
|
1,516 |
1,078 |
$2.24 |
| 81002 |
|
49 |
32 |
$2.03 |
| 99173 |
|
1,883 |
1,266 |
$1.91 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,553 |
1,092 |
$0.92 |
| 96160 |
|
6,205 |
4,722 |
$0.00 |
| 92552 |
|
1,623 |
1,076 |
$0.00 |
| 90461 |
|
1,197 |
816 |
$0.00 |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
457 |
351 |
$0.00 |
| G0511 |
Rural health clinic or federally qualified health center (rhc or fqhc) only, general care management, 20 minutes or more of clinical staff time for chronic care management services or behavioral health integration services directed by an rhc or fqhc practitioner (physician, np, pa, or cnm), per calendar month |
667 |
602 |
$0.00 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
896 |
355 |
$0.00 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
179 |
139 |
$0.00 |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
386 |
288 |
$0.00 |
| 81025 |
|
564 |
386 |
$0.00 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
39 |
29 |
$0.00 |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
446 |
316 |
$0.00 |
| 90832 |
Psychotherapy, 30 minutes with patient |
170 |
80 |
$0.00 |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
105 |
84 |
$0.00 |
| 90633 |
|
61 |
59 |
$0.00 |
| 90671 |
|
38 |
25 |
$0.00 |
| 90791 |
Psychiatric diagnostic evaluation |
155 |
104 |
$0.00 |
| 90734 |
|
79 |
53 |
$0.00 |
| S0028 |
Injection, famotidine, 20 mg |
24 |
13 |
$0.00 |
| 90670 |
|
153 |
121 |
$0.00 |
| 90837 |
Psychotherapy, 53 minutes with patient |
87 |
44 |
$0.00 |
| 90649 |
|
103 |
85 |
$0.00 |
| 99177 |
|
148 |
70 |
$0.00 |
| 83655 |
|
63 |
51 |
$0.00 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
360 |
275 |
$0.00 |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
61 |
47 |
$0.00 |
| Q0091 |
Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory |
118 |
101 |
$0.00 |
| 82948 |
|
104 |
75 |
$0.00 |
| 0002A |
|
21 |
13 |
$0.00 |
| S0164 |
Injection, pantoprazole sodium, 40 mg |
140 |
97 |
$0.00 |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
152 |
127 |
$0.00 |
| 99215 |
Prolong outpt/office vis |
13 |
13 |
$0.00 |
| J2010 |
Injection, lincomycin hcl, up to 300 mg |
21 |
12 |
$0.00 |
| 90700 |
|
15 |
12 |
$0.00 |
| 90710 |
|
14 |
14 |
$0.00 |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
29 |
26 |
$0.00 |
| 3078F |
|
39 |
24 |
$0.00 |
| D0145 |
Oral evaluation for a patient under three years of age |
69 |
42 |
$0.00 |
| 99442 |
|
15 |
14 |
$0.00 |
| 99000 |
|
2,909 |
1,776 |
$0.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
2,557 |
1,797 |
$0.00 |
| 90674 |
|
61 |
48 |
$0.00 |
| G0467 |
Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit |
1,759 |
1,269 |
$0.00 |
| 3074F |
|
289 |
200 |
$0.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
2,497 |
1,672 |
$0.00 |
| 85018 |
|
1,992 |
1,263 |
$0.00 |
| 3079F |
|
530 |
377 |
$0.00 |
| 36416 |
|
491 |
381 |
$0.00 |
| 3048F |
|
365 |
254 |
$0.00 |
| 90686 |
|
383 |
288 |
$0.00 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,526 |
802 |
$0.00 |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
25 |
13 |
$0.00 |
| H0049 |
Alcohol and/or drug screening |
86 |
57 |
$0.00 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
25 |
13 |
$0.00 |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
118 |
96 |
$0.00 |
| 3049F |
|
132 |
108 |
$0.00 |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
40 |
25 |
$0.00 |
| 0012A |
|
49 |
19 |
$0.00 |
| 0011A |
|
49 |
27 |
$0.00 |
| 3080F |
|
110 |
68 |
$0.00 |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
523 |
418 |
$0.00 |
| 99174 |
|
658 |
455 |
$0.00 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
18 |
13 |
$0.00 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
315 |
237 |
$0.00 |
| 3075F |
|
79 |
51 |
$0.00 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
108 |
81 |
$0.00 |
| 99441 |
|
155 |
99 |
$0.00 |
| 90620 |
|
27 |
24 |
$0.00 |
| 92551 |
|
39 |
34 |
$0.00 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
84 |
56 |
$0.00 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
51 |
27 |
$0.00 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
19 |
16 |
$0.00 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
14 |
12 |
$0.00 |